Figure 2
Figure 2. Increased proportion of cycling (Ki67+) CD4+ and CD4+CD127+ T cells persists up to M12 after ART, whereas the proportion of cycling CD8+ and CD8+CD127+ T-cell normalizes shortly after ART initiation. The proportion of cycling CD4+ (A), CD8+ (B), CD3+ (C), CD4+CD127+ (D), CD8+CD127+ (E), CD3+CD127+ (F), CD4+CD127− (G), CD8+CD127− (H), and CD3+CD127− (I) is shown in the group of HIV+ patients (n = 30) who were followed longitudinally from M0 to M24. Circles (black) represent median values, and bars indicate interquartile range (IQR). Gray dashed lines indicate HC median values. P values (gray) at the top of the graphs represent unpaired comparison between HC and HIV+ at each time point, and P values (black) above the IQR bars indicate paired comparison of HIV+ patients at each time point during the therapy to the pretherapy level (M0). Significant P values < .01 are reported, *P = .01 > .001, **P = .001 ≥ .0001, and ***P < .0001.

Increased proportion of cycling (Ki67+) CD4+ and CD4+CD127+ T cells persistsup to M12 after ART, whereas the proportion of cycling CD8+ and CD8+CD127+ T-cell normalizes shortly after ART initiation. The proportion of cycling CD4+ (A), CD8+ (B), CD3+ (C), CD4+CD127+ (D), CD8+CD127+ (E), CD3+CD127+ (F), CD4+CD127 (G), CD8+CD127 (H), and CD3+CD127 (I) is shown in the group of HIV+ patients (n = 30) who were followed longitudinally from M0 to M24. Circles (black) represent median values, and bars indicate interquartile range (IQR). Gray dashed lines indicate HC median values. P values (gray) at the top of the graphs represent unpaired comparison between HC and HIV+ at each time point, and P values (black) above the IQR bars indicate paired comparison of HIV+ patients at each time point during the therapy to the pretherapy level (M0). Significant P values < .01 are reported, *P = .01 > .001, **P = .001 ≥ .0001, and ***P < .0001.

Close Modal

or Create an Account

Close Modal
Close Modal